Blog GLP-1 Drugs for Addiction Are Moving From Anecdote to Evidence. A 2026 Trial Suggests Semaglutide Can Blunt the Urge to Drink. Read More
Regulation Federal Mental Health Parity Enforcement Has Stalled Under a Paused 2024 Rule. The Quieter Story of 2026 Is the State Regulators, Statutory Mandates, and Private Litigants Now Filling the Gap. Read More
Regulation Medicaid Work Requirements: New CMS Rule Ties Mental Illness and Addiction Exemptions to Whether a Beneficiary Can Work Read More
